Nektar Therapeutics
NKTR
#6053
Rank
โ‚น95.75 B
Marketcap
โ‚น2,799
Share price
-7.19%
Change (1 day)
-47.71%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -โ‚น14.08 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚น54.58 Million. In 2025 the company made an earning of -โ‚น14.41 Billion a decrease over its 2024 earnings that were of -โ‚น11.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น14.08 Billion-2.28%
2025 -โ‚น14.41 Billion30.44%
2024 -โ‚น11.05 Billion-56.85%
2023 -โ‚น25.61 Billion-24.31%
2022 -โ‚น33.83 Billion-30.25%
2021 -โ‚น48.5 Billion17.87%
2020 -โ‚น41.15 Billion0.88%
2019 -โ‚น40.78 Billion-164.46%
2018 โ‚น63.26 B-810.61%
2017 -โ‚น8.91 Billion-37.06%
2016 -โ‚น14.15 Billion89.22%
2015 -โ‚น7.48 Billion48.22%
2014 -โ‚น5.05 Billion-65.93%
2013 -โ‚น14.81 Billion-6.81%
2012 -โ‚น15.89 Billion28.95%
2011 -โ‚น12.33 Billion258.8%
2010 -โ‚น3.44 Billion-63.94%
2009 -โ‚น9.53 Billion-392.45%
2008 โ‚น3.25 B-211.74%
2007 -โ‚น2.92 Billion-79.57%
2006 -โ‚น14.27 Billion-16.9%
2005 -โ‚น17.17 Billion81.53%
2004 -โ‚น9.46 Billion54.19%
2003 -โ‚น6.14 Billion-33.87%
2002 -โ‚น9.28 Billion-9.6%
2001 -โ‚น10.26 Billion73.39%
2000 -โ‚น5.92 Billion108.9%
1999 -โ‚น2.84 Billion39.48%
1998 -โ‚น2.04 Billion60.02%
1997 -โ‚น1.27 Billion18.05%
1996 -โ‚น1.08 Billion31.82%
1995 -โ‚น0.82 Billion57.14%
1994 -โ‚น0.52 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.734 T-12,326.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น645.72 B-4,650.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1.024 T-7,318.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น17.33 Billion 22.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น623.02 B-4,490.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.398 T-9,954.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น0.94 B-106.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น16.18 B-214.07%๐Ÿ‡ฎ๐Ÿ‡ช Ireland